Resource utilisation and cost of cervical cancer and dysplasia in Croatia
Journal Title: European Journal of Gynaecological Oncology - Year 2019, Vol 40, Issue 1
Abstract
Purpose of investigation: To analyse resource utilisation and costs due to cervical cancer and dysplasia in Croatia. Materials and Methods: Patients diagnosed with cervical cancer were identified from the Croatian National Cancer Registry. Resource utilisation and costs of cervical cancer treatment for the period of five years after the date of diagnosis were retrieved from the Croatian Health Insurance Fund Claims Database. Patients diagnosed with cervical dysplasia were identified and their resource utilisation and treatment costs during one year following diagnosis were obtained from the Croatian Health Insurance Fund Claims Database. Results were calculated for different healthcare services and disease stages. Results: There were 346 patients diagnosed with cervical cancer in 2008. Total costs of treatment in the five-year period were 2,177,071 Euros, while average cost of treatment per patient was 6,403 Euros. The largest shares of total costs were costs for hospitalisations (73%), followed by outpatient healthcare (17%), and personal sick leave (7%). There were also 14,913 patients with cervical dysplasia diagnosed in 2012. Total costs of their treatment during one year after the diagnosis were 1,609,073 Euros, with average costs per patient of 108 Euros. Outpatient care (48%), followed by hospitalisations (45%), and prescribed medicines (6%) had the greatest share of total costs. Conclusion: Treatment of cervical cancer and dysplasia in Croatia is associated with significant costs and healthcare resource utilisation.
Authors and Affiliations
A. Ivičević Uhernik, M. Vajagić, Z. Lovrić
Keywords
Related Articles
- EP ID EP626315
- DOI 10.12892/ejgo4210.2019
- Views 80
- Downloads 0
Diffusion magnetic resonance in cervical carcinoma: the role of apparent diffusion coefficient in the evaluation of treatment response
Purpose: The aim of the study was to determinate the role of apparent diffusion coefficient (ADC) in order to find cut-off values in the evaluation of treatment response. Materials and Methods: A retrospective study was...
Concurrent chemoradiotherapy combined with immunotherapy is superior to traditional concurrent chemoradiotherapy in the treatment of advanced cervical cancer
Purpose of investigation: In advanced cervical cancer, traditional therapy included concurrent chemoradiotherapy (CCRT), pelvic radiotherapy, and brachytherapy. In the last few years, the development of using of immunoth...
Plasma fibrinogen, CRP, and hs-CRP levels in patients with benign and borderline ovarian tumours
Objective: Ovarian tumours can be classified as benign, borderline or malignant lesions. The purpose of this study was to assess, inter alia, fibrinogen concentration, and the (C-reactive proteins) and high-sensitivity C...
Risk of cervical cancer and squamous intraepithelial lesions according to human papillomavirus high-risk serotypes detected by qualitative real-time in vitro PCR
Purpose of investigation: To establish the relationship between high-risk human papillomavirus (hrHPV) serotypes and the odds of developing cervical intraepithelial lesions. Material and Methods: Retrospective cohort stu...
Cytoreductive surgery combined with HIPEC in newly diagnosed and recurrent ovarian cancer
Objective: Perioperative intraperitoneal chemotherapy after cytoreductive surgery is used in ovarian cancer treatment. The purpose of the study is the evaluation of the effect of hyperthermic intraoperative intraperitone...